Industry
U.S. military to spend $73 million to develop room-temperature artificial blood, aims for 2029 deployment
The U.S. Defense Advanced Research Projects Agency has launched a programme to develop blood substitutes that can be stored for long periods at room temperature, aiming to ease shortages on the battlefield. The $73 million RAPIID effort seeks longer-lasting plasma, platelets and red blood cell substitutes and targets field deployment in 2029. Candidate technologies will be tested in parallel, moving from large-animal work to human trials under University of Colorado Anschutz oversight.
